Absci (ABSI) Deferred Taxes (2021 - 2024)
Absci's (ABSI) quarterly Deferred Taxes came in at -$11000.0 in Q1 2024, up 21.43% year-on-year from -$9058.8 in Q2 2023, and up 82.54% quarter-over-quarter from -$63000.0 in Q4 2023.
Absci (ABSI) Deferred Taxes (2021 - 2024) Analysis & Trends
Absci has disclosed Deferred Taxes across 4 years of filings, most recently posting -$11000.0 for Q1 2024.
- Deferred Taxes for Q1 2024 came in at -$11000.0, up 21.43% year-over-year; the trailing twelve-month figure through Jun 2024 was -$48000.0 (up 94.43% YoY), and the FY2023 annual result was -$52000.0, up 89.7% from the prior year.
- Deferred Taxes came in at -$11000.0 for Q1 2024 at Absci, up from -$63000.0 in the prior quarter.
- In the past five years, Deferred Taxes ranged from a high of $616000.0 in Q1 2022 to a low of -$5.6 million in Q2 2021.
- The 4-year median for Deferred Taxes is -$274000.0 (2022), against an average of -$728384.6.
- Across the five-year window, Deferred Taxes jumped 229.14% in 2022 and slumped 102.27% in 2023, its largest moves.
- Absci's Deferred Taxes stood at -$1.1 million in 2021, then surged by 53.08% to -$518000.0 in 2022, then surged by 87.84% to -$63000.0 in 2023, then jumped by 82.54% to -$11000.0 in 2024.
- The last three Deferred Taxes figures came in at -$11000.0 (Q1 2024), -$63000.0 (Q4 2023), and $26000.0 (Q3 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -859,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -65.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Absci | 1.13 Bn | 1.01 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | -11,000.00 |
| Dec 31, 2023 | -63,000.00 |
| Sep 30, 2023 | 26,000.00 |
| Jun 30, 2023 | -1,000.00 |
| Mar 31, 2023 | -14,000.00 |
| Dec 31, 2022 | -518,000.00 |
| Sep 30, 2022 | -329,000.00 |
| Jun 30, 2022 | -274,000.00 |
| Mar 31, 2022 | 616,000.00 |
| Dec 31, 2021 | -1.10 Mn |
| Sep 30, 2021 | -1.70 Mn |
| Jun 30, 2021 | -5.62 Mn |
| Mar 31, 2021 | -477,000.00 |